ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant – News-Medical.Net

The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford’s ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.3… [read more]